BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9806017)

  • 1. Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children.
    Sullender WM; Mufson MA; Prince GA; Anderson LJ; Wertz GW
    J Infect Dis; 1998 Oct; 178(4):925-32. PubMed ID: 9806017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and immunogenic analysis of group A and group B respiratory syncytial virus G proteins expressed from recombinant baculoviruses.
    Sullender WM; Britt WJ
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():641-8. PubMed ID: 8627252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual antigenic and genetic characteristics of human respiratory syncytial viruses isolated in Cuba.
    Valdés O; Martínez I; Valdivia A; Cancio R; Savón C; Goyenechea A; Melero JA
    J Virol; 1998 Sep; 72(9):7589-92. PubMed ID: 9696858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence conservation in the attachment glycoprotein and antigenic diversity among bovine respiratory syncytial virus isolates.
    Stine LC; Hoppe DK; Kelling CL
    Vet Microbiol; 1997 Mar; 54(3-4):201-21. PubMed ID: 9100323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
    Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
    J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection.
    Gaddum RM; Cook RS; Wyld SG; López JA; Bustos R; Melero JA; Taylor G
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1239-48. PubMed ID: 8683212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.
    Melero JA; García-Barreno B; Martínez I; Pringle CR; Cane PA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2411-8. PubMed ID: 9349459
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic and genetic variability of human respiratory syncytial viruses (group A) isolated in Uruguay and Argentina: 1993-2001.
    Frabasile S; Delfraro A; Facal L; Videla C; Galiano M; de Sierra MJ; Ruchansky D; Vitureira N; Berois M; Carballal G; Russi J; Arbiza J
    J Med Virol; 2003 Oct; 71(2):305-12. PubMed ID: 12938207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.
    García O; Martín M; Dopazo J; Arbiza J; Frabasile S; Russi J; Hortal M; Perez-Breña P; Martínez I; García-Barreno B
    J Virol; 1994 Sep; 68(9):5448-59. PubMed ID: 8057427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against respiratory syncytial virus infection by DNA immunization.
    Li X; Sambhara S; Li CX; Ewasyshyn M; Parrington M; Caterini J; James O; Cates G; Du RP; Klein M
    J Exp Med; 1998 Aug; 188(4):681-8. PubMed ID: 9705950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.
    Sullender WM; Mufson MA; Anderson LJ; Wertz GW
    J Virol; 1991 Oct; 65(10):5425-34. PubMed ID: 1895391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community.
    Peret TC; Hall CB; Schnabel KC; Golub JA; Anderson LJ
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2221-9. PubMed ID: 9747732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.
    Sullender W
    Virology; 1995 May; 209(1):70-9. PubMed ID: 7747486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
    Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
    J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus: reverse genetics and vaccine strategies.
    Collins PL; Murphy BR
    Virology; 2002 May; 296(2):204-11. PubMed ID: 12069519
    [No Abstract]   [Full Text] [Related]  

  • 20. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
    Spender LC; Hussell T; Openshaw PJ
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.